-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Senti Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2021 to 2023.
- Senti Biosciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$15.2M, a 65.3% increase year-over-year.
- Senti Biosciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$63.6M, a 27.6% increase year-over-year.
- Senti Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$92.7M, a 49.4% decline from 2022.
- Senti Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$62.1M, a 53.5% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)